Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
11.70
0.17 (1.47%)
At close: Jun 16, 2025, 3:59 PM
Stoke Therapeutics Revenue
Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending March 31, 2025, Stoke Therapeutics generated $158.57M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
638.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|